Michele Goulart dos Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Michele Goulart dos Santos has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Lucia Emanueli Schimith
3 shared publicationsBruno Dutra Arbo
2 shared publicationsClaude Solleux
2 shared publications- Mariana Appel Hort
Programa de Pós-graduação em Ciências da Saúde, Faculdade de Medicina, Universidade Federal do Rio Grande (FURG), Rua Visconde de Paranaguá, 102, Rio Grande 96203-900, RS, Brazil
2 shared publications Marie Demonceaux
2 shared publicationsAdriel Antonio Schirmann
Toxicological Biochemistry, Center of Natural and Exact Sciences, Federal University of Santa Maria, Santa Maria, Brazil
1 shared publication
Latest Publications
- Open Access
- 31 October 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (6) , 315
Caffeic Acid Regulates High Glucose-Induced Inflammatory Responses in BV-2 Microglial Cells: Implications for Purinergic Signaling
High glucose-induced microglial activation contributes to inflammatory processes associated with diabetic complications. Thus, the effects of caffeic acid (CA) on inflammatory responses and purinergic signaling parameters in high glucose-challenged BV-2 microglial cells were investigated. A) Oxidative stress; b) Enzymatic activities of Ecto-nucleoside triphosphate diphosphohydrolase (E-NTPDase), Ecto-5-nucleotidase (E-5’-NT), and Adenosine deaminase (ADA); c) Density of P2X7R, A1R, and A2AR purinoceptors; d) Inflammatory markers (IBA-1, NLRP3, and IL-1β); and e) Apoptosis and cell cycle were assessed. Treatment with CA (50 and 75 µM, 24 h) in cells exposed to high glucose medium (GL 25 mM, 48 h) increased viability and reduced nitric oxide (NO), reactive species (RS), and thiobarbituric acid reactive substances (TBARS) levels compared to high glucose-challenged cells. CA also restored ATP and ADP hydrolysis and reduced ADA activity. Furthermore, CA increased the density of the A1R while reversing the high glucose-induced increase in P2X7R and A2AR densities. Moreover, CA treatment attenuated the increase in IL-1β density in high glucose medium, whereas only CA (75 µM) treatment reduced NLRP3 and IBA-1 densities. Besides, this phenolic compound decreased apoptosis and promoted cell cycle progression by increasing the proportion of cells in the S and G2/M phases. Overall, findings suggest that CA attenuates high glucose-induced inflammatory and oxidative alterations in BV-2 microglial cells, besides modulating purinergic enzyme activities and purinoceptor density. These results support the potential involvement of purinergic signaling in the cellular effects of CA and provide possible mechanistic insights into its antioxidant and anti-inflammatory actions under high glucose conditions.
- 31 October 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (6) , 315
Open AccessCaffeic Acid Regulates High Glucose-Induced Inflammatory Responses in BV-2 Microglial Cells: Implications for Purinergic Signaling
High glucose-induced microglial activation contributes to inflammatory processes associated with diabetic complications. Thus, the effects of caffeic acid (CA) on inflammatory responses and purinergic signaling parameters in high glucose-challenged BV-2 microglial cells were investigated. A) Oxidative stress; b) Enzymatic activities of Ecto-nucleoside triphosphate diphosphohydrolase (E-NTPDase), Ecto-5-nucleotidase (E-5’-NT), and Adenosine deaminase (ADA); c) Density of P2X7R, A1R, and A2AR purinoceptors; d) Inflammatory markers (IBA-1, NLRP3, and IL-1β); and e) Apoptosis and cell cycle were assessed. Treatment with CA (50 and 75 µM, 24 h) in cells exposed to high glucose medium (GL 25 mM, 48 h) increased viability and reduced nitric oxide (NO), reactive species (RS), and thiobarbituric acid reactive substances (TBARS) levels compared to high glucose-challenged cells. CA also restored ATP and ADP hydrolysis and reduced ADA activity. Furthermore, CA increased the density of the A1R while reversing the high glucose-induced increase in P2X7R and A2AR densities. Moreover, CA treatment attenuated the increase in IL-1β density in high glucose medium, whereas only CA (75 µM) treatment reduced NLRP3 and IBA-1 densities. Besides, this phenolic compound decreased apoptosis and promoted cell cycle progression by increasing the proportion of cells in the S and G2/M phases. Overall, findings suggest that CA attenuates high glucose-induced inflammatory and oxidative alterations in BV-2 microglial cells, besides modulating purinergic enzyme activities and purinoceptor density. These results support the potential involvement of purinergic signaling in the cellular effects of CA and provide possible mechanistic insights into its antioxidant and anti-inflammatory actions under high glucose conditions.
- Open Access
- 31 August 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (5) , 258
Comparative Effects of Quercetin and its α- and β-D-glucoside Derivatives in LPS-Stimulated C6 Astroglial Cells
- 31 August 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (5) , 258
Open AccessComparative Effects of Quercetin and its α- and β-D-glucoside Derivatives in LPS-Stimulated C6 Astroglial Cells
- Open Access
- 30 June 2025
- Published by Associacao Brasileira de Criminalistica - ABC in Revista Brasileira de Criminalística
- Vol. 14 (2) , 109-133
Analytical detection of New Psychoactive Substances in biological samples: a Systematic Review
New psychoactive substances (NPS) are substances of abuse that have posed a significant threat in recent years. Accurate detection of NPS presents a major analytical challenge due to their structural diversity and their rapid emergence and disappearance from the market. In this context, given the wide structural variety of the different classes of NPS developed to circumvent legislation and the difficulties authorities face in detecting these compounds, the objective of this work was to perform a systematic review of the main analytical methods recently validated for the identification of NPS in biological matrices, as well as the primary sample preparation methods used in the detection process. The methodology followed the PRISMA-S guidelines, and studies were selected based on predefined inclusion and exclusion criteria. Ultimately, 74 studies were included in this review for data extraction. Blood was the most commonly analyzed biological matrix for the identification of NPS, and solid-phase extraction was the most frequently employed sample preparation method. Liquid chromatography, using a C18 column as the stationary phase and coupled with high-resolution mass spectrometry (LC-HRMS), emerged as the most commonly used analytical technique due to its high sensitivity and specificity in identifying NPS, with stimulants being the most prevalent class in the included studies. It is important to emphasize that there is no single ideal method for identifying NPS. A combination of different analytical tools may often be required to evaluate these substances, given their frequent structural modifications. This dynamic nature necessitates the continuous updating of detection methods by authorities.
- 30 June 2025
- Published by Associacao Brasileira de Criminalistica - ABC in Revista Brasileira de Criminalística
- Vol. 14 (2) , 109-133
Open AccessAnalytical detection of New Psychoactive Substances in biological samples: a Systematic Review
New psychoactive substances (NPS) are substances of abuse that have posed a significant threat in recent years. Accurate detection of NPS presents a major analytical challenge due to their structural diversity and their rapid emergence and disappearance from the market. In this context, given the wide structural variety of the different classes of NPS developed to circumvent legislation and the difficulties authorities face in detecting these compounds, the objective of this work was to perform a systematic review of the main analytical methods recently validated for the identification of NPS in biological matrices, as well as the primary sample preparation methods used in the detection process. The methodology followed the PRISMA-S guidelines, and studies were selected based on predefined inclusion and exclusion criteria. Ultimately, 74 studies were included in this review for data extraction. Blood was the most commonly analyzed biological matrix for the identification of NPS, and solid-phase extraction was the most frequently employed sample preparation method. Liquid chromatography, using a C18 column as the stationary phase and coupled with high-resolution mass spectrometry (LC-HRMS), emerged as the most commonly used analytical technique due to its high sensitivity and specificity in identifying NPS, with stimulants being the most prevalent class in the included studies. It is important to emphasize that there is no single ideal method for identifying NPS. A combination of different analytical tools may often be required to evaluate these substances, given their frequent structural modifications. This dynamic nature necessitates the continuous updating of detection methods by authorities.
- Open Access
- 9 May 2025
- Published by Wiley in Chemistry & Biodiversity
- Vol. 22 (8) , e202500119
Pharmacokinetic Prediction and Cytotoxicity of New Quercetin Derivatives
Quercetin (QUE) possesses various pharmacological properties; however, its low bioavailability and solubility hinder its beneficial effects. Enzymatic glycosylation has been explored to improve these aspects. In the present study, we used a sucrose phosphorylase variant to catalyze the regioselective transglucosylation of QUE, predicted the pharmacokinetic properties and toxicity of these molecules using in silico tools, and evaluated their cytotoxicity compared to the original molecule and a β‐glucosylated derivative of QUE. Three α‐glucosylated derivatives were obtained, which demonstrated improved pharmacokinetics, including a higher volume of distribution and lower clearance rate, with minimal likelihood of cytochrome P450 enzyme inhibition compared to QUE. QUE and the β‐glucosylated derivative exhibited cytotoxicity in both cell types evaluated, whereas their α‐glucosylated derivatives were nontoxic. The results presented provide an insight into the predicted behavior of these molecules in the body and, combined with cytotoxicity evaluation, will serve as a foundation for investigating the biological effects and mechanisms of action of these new molecules.
- 9 May 2025
- Published by Wiley in Chemistry & Biodiversity
- Vol. 22 (8) , e202500119
Open AccessPharmacokinetic Prediction and Cytotoxicity of New Quercetin Derivatives
Quercetin (QUE) possesses various pharmacological properties; however, its low bioavailability and solubility hinder its beneficial effects. Enzymatic glycosylation has been explored to improve these aspects. In the present study, we used a sucrose phosphorylase variant to catalyze the regioselective transglucosylation of QUE, predicted the pharmacokinetic properties and toxicity of these molecules using in silico tools, and evaluated their cytotoxicity compared to the original molecule and a β‐glucosylated derivative of QUE. Three α‐glucosylated derivatives were obtained, which demonstrated improved pharmacokinetics, including a higher volume of distribution and lower clearance rate, with minimal likelihood of cytochrome P450 enzyme inhibition compared to QUE. QUE and the β‐glucosylated derivative exhibited cytotoxicity in both cell types evaluated, whereas their α‐glucosylated derivatives were nontoxic. The results presented provide an insight into the predicted behavior of these molecules in the body and, combined with cytotoxicity evaluation, will serve as a foundation for investigating the biological effects and mechanisms of action of these new molecules.
- 5 February 2022
- Published by Elsevier in European Journal of Pharmacology
- Vol. 919, 174800
Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation
- 5 February 2022
- Published by Elsevier in European Journal of Pharmacology
- Vol. 919, 174800
Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation